Inheritance | Disease phenotype | Key references | Gene symbol (chromosome) protein |
| AR | Abetalipoproteinemia | | | microsomal triglyceride transfer protein
|
|
| AR | Acetylcholine receptor deficiency | | | cholinergic receptor, nicotinic, beta 1 muscle
|
|
| AR | Acetylcholine receptor deficiency | | | cholinergic receptor, nicotinic, delta
|
|
| AR | Acetylcholine receptor deficiency | | | cholinergic receptor, nicotinic, epsilon
|
|
| AR | Acyl-CoA dehydrogenase (very long chain) deficiency (VLCAD deficiency) | | | acyl-Coenzyme A dehydrogenase, very long chain
|
|
| AR | Amyotrophic lateral sclerosis, juvenile | | |
| AR | Arthrogryposis multiplex congenita with nesprin-1 defect | | | spectrin repeat containing, nuclear envelope 1 (nesprin 1)
|
|
| AR | Ataxia oculomotor apraxia 1 | | |
| AR | Ataxia oculomotor Apraxia 2 | | |
| AR | Ataxia telangiectasia | | | ataxia telangiectasia mutated
|
|
| AR | Ataxia telangiectasia-like disorder | | | MRE11 meiotic recombination 11 homolog A
|
|
| AR | Autosomal recessive spastic ataxia 2 | | ? - (17p13) |
| AR | Autosomal recessive spastic ataxia 3 (with leukoencephalopathy) | | ? - (2q33-34) |
| AR | Autosomal recessive spastic ataxia of Charlevoix-Saguenay | | |
| AR | Autosomal recessive spastic ataxia of Charlevoix-Saguenay | | |
| AR | Autosomal recessive spinocerebellar ataxia, 3 | | ? - (6p23-p21) |
| AR | Autosomal recessive spinocerebellar ataxia, 4 | | ? - (1p36) |
| AR | Autosomal recessive spinocerebellar ataxia, 5 | | ? - (15q24-q26) |
| AR | Autosomal recessive spinocerebellar ataxia, 6 | | ? - (20q11-q13) |
| AR | Autosomal recessive spinocerebellar ataxia, 7 | | ? - (11p15) |
| AR | Autosomal recessive spinocerebellar ataxia, 8 | | | spectrin repeat containing, nuclear envelope 1 (nesprin 1)
|
|
| AR | Autosomal recessive spinocerebellar ataxia, 9 (with ubiquinone deficiency) | | | chaperone, ABC1 activity of bc1 complex homolog (S. pombe)
|
|
| AR | Bethlem myopathy (recessive) | | |
| AR | Carnitine acylcarnitine translocase deficiency | | | carnitine-acylcarnitine translocase
|
|
| AR | Carnitine palmitoyl-transferase deficiency | | | carnitine palmitoyltransferase II
|
|
| AR | Central core disease, recessive (transient multiminicore myopathy) | | | ryanodine receptor 1 (skeletal)
|
|
| AR | Centronuclear myopathy, recessive | | |
| AR | Centronuclear myopathy, recessive | | | ryanodine receptor 1 (skeletal)
|
|
| AR | Charcot-Marie-Tooth neuropathy Autosomal recessive CMT2A | | |
| AR | Charcot-Marie-Tooth neuropathy Autosomal recessive CMT2B | | | mediator complex subunit 25
|
|
| AR | Charcot-Marie-Tooth neuropathy Type 4A | | | ganglioside-induced differentiation-associated protein 1
|
|
| AR | Charcot-Marie-Tooth neuropathy Type 4B1 | | | myotubularin-related protein 2
|
|
| AR | Charcot-Marie-Tooth neuropathy Type 4B2 | | |
| AR | Charcot-Marie-Tooth neuropathy Type 4C | | |
| AR | Charcot-Marie-Tooth neuropathy Type 4D (HMSN Lom, with deafness) | | | N-myc downstream regulated gene 1
|
|
| AR | Charcot-Marie-Tooth neuropathy Type 4F | | |
| AR | Charcot-Marie-Tooth neuropathy Type 4G (type Russe) | | ? - (10q22) |
| AR | Charcot-Marie-Tooth neuropathy Type 4H | | | actin-filament binding protein Frabin
|
|
| AR | Charcot-Marie-Tooth neuropathy Type 4J | | | polyphosphoinositide phosphatase activity
|
|
| AR | Congenital cataracts, facial dysmorphism and neuropathy | | | CTD phosphatase subunit 1
|
|
| AR | Congenital fibrosis of the extraocular muscles | | | paired-like aristaless homeobox protein 2A
|
|
| AR | Congenital lethal myopathy | | |
| AR | Congenital muscle dystrophy with joint hyperlaxity | | ? - (3p23-21) |
| AR | Congenital muscle dystrophy with mitochondrial structural abnormalities (megaconial type) | | |
| AR | Congenital muscular dystrophy and abnormal glycosylation of dystroglycan | | |
| AR | Congenital muscular dystrophy and abnormal glycosylation of dystroglycan | | |
| AR | Congenital muscular dystrophy with integrin defect | | | integrin alpha 7 precursor
|
|
| AR | Congenital muscular dystrophy with merosin deficiency | | ? - (1q42) |
| AR | Congenital muscular dystrophy with merosin deficient | | | laminin alpha 2 chain of merosin
|
|
| AR | Congenital musuclar dystrophy with telethonin defect | | |
| AR | Congenital myasthenic syndrome with agrin deficiency | | |
| AR | Congenital myasthenic syndrome with Beta2-laminin deficiency | | | laminin, beta 2 (laminin S)
|
|
| AR | Congenital myasthenic syndrome with choline acetyltransferase deficiency | | | choline acetyltransferase isoform
|
|
| AR | Congenital myasthenic syndrome with end-plate acetylcholin-esterase deficiency | | | acetylcholinesterase collagen-like tail subunit
|
|
| AR | Congenital myasthenic syndrome with MuSK deficiency | | | skeletal muscle receptor tyrosine kinase
|
|
| AR | Congenital myasthenic syndrome with rapsyn deficiency | | |
| AR | Congenital myasthenic syndrome, type Ia1 | | ? - (17q13) |
| AR | Congenital skeletal myopathy and fatal cardiomyopathy | | | cardiac myosin binding protein-C
|
|
| AR | Dejerine-Sottas hypertrophic neuropathy, recessive | | |
| AR | Dilated cardiomyopathy due to fukutin defect | | |
| AR | Distal myopathy with nebulin defect | | |
| AR | Distal myopathy with rimmed vacuoles (Nonaka) and Hereditary inclusion body myopathy | | | UDP-N-acetylglucosamine-2- epimerase/N-acetylmannosamine kinase
|
|
| AR | Distal recessive myopathy (Miyoshi myopathy) | | |
| AR | Early onset calf distal myopathy | | |
| AR | Emery-Dreifuss muscular dystrophy, autosomal recessive | | |
| AR | Epidermolysis bullosa simplex associated with late-onset muscular dystrophy | | | plectin 1, intermediate filament binding protein 500kDa
|
|
| AR | Escobar syndrome (multiple pterygium syndrome) | | | cholinergic receptor, nicotinic, gamma polypeptide
|
|
| AR | Familial amyotrophic lateral sclerosis | | ? - (18q21) |
| AR | Familial amyotrophic lateral sclerosis (recessive) | | | superoxide dismutase 1, soluble
|
|
| AR | Familial dysautonomia (Riley-Day syndrome) | | | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
| AR | Familial limb girdle myasthenia with tubular aggregates | | | glutamine-fructose-6-phosphate transaminase 1
|
|
| AR | Familial limb-girdle myasthenia | | |
| AR | Fast channel syndrome | | | cholinergic receptor, nicotinic, alpha polypeptide 1
|
|
| AR | Fast channel syndrome | | | cholinergic receptor, nicotinic, delta
|
|
| AR | Fast channel syndrome | | | cholinergic receptor, nicotinic, epsilon
|
|
| AR | Friedreich ataxia 1 | | |
| AR | Friedreich ataxia 2 | | ? - (9p23-p11) |
| AR | Friedreich ataxia with selective vitamin E deficiency | | | tocopherol (alpha) transfer protein (ataxia (Friedreich-like) with vitamin E deficiency)
|
|
| AR | Fukuyama congenital muscular dystrophy | | |
| AR | Giant axonal neuropathy | | |
| AR | Glycogen storage disease type 0 | | | glycogen synthase 3 glycogen synthase 1 (muscle) glycogen synthase 1 (muscle)
|
|
| AR | Glycogen storage disease Type II (Pompe) | | | acid alpha-glucosidase preproprotein
|
|
| AR | Glycogen storage disease type IIIa | | | Amylo-1,6-glucosidase, 4-alpha-glucanotransferase
|
|
| AR | Glycogen storage disease type IV | | | glucan (1,4-alpha-), branching enzyme 1 (glycogen branching enzyme, Andersen disease, glycogen storage disease type IV)
|
|
| AR | Glycogen storage disease Type V (McArdle) | | |
| AR | Glycogen storage disease Type VII (Tarui) | | | phosphofructokinase, muscle
|
|
| AR | Glycogenosis type XIV | | |
| AR | Glycogenosis type XV | | |
| AR | Hereditary motor and sensory neuropathy-Lom (with deafness) | | | N-myc downstream regulated gene 1
|
|
| AR | Hereditary sensory and autonomic neuropathy type II | | | WNK lysine deficient protein kinase 1
|
|
| AR | Hereditary sensory and autonomic neuropathy type III (Familial dysautonomia, Riley-Day syndrome) | | | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein
|
|
| AR | Hereditary sensory and autonomic neuropathy type V | | | nerve growth factor (beta polypeptide)
|
|
| AR | Hyaline body myopathy | | ? - (3p22.2-p21.32) |
| AR | Hypertrophic mitochondrial cardiomyopathy with MRPL3 defect | | | mitochondrial ribosomal protein L3
|
|
| AR | Hypertrophic cardiomyopathy, early-onset fatal by deficit in COX15 | | | COX15 homolog, cytochrome c oxidase assembly protein (yeast)
|
|
| AR | Infantile-onset ascending spastic paraplegia | | |
| AR | Infantile-onset spinocerebellar ataxia | | | twinkle/twinky (mt DNA helicase)
|
|
| AR | Jervell and Lange-Nielsen cardio-auditory syndrome | | | potassium voltage-gated channel, KQT-like subfamily, member 1
|
|
| AR | Jervell and Lange-Nielsen cardio-auditory syndrome | | | potassium voltage-gated channel, Isk-related family, member 2
|
|
| AR | Lactate dehydrogenase-A deficiency | | |
| AR | Lethal Congenital Contracture Syndrome 1 | | | GLE1 RNA export mediator homolog (yeast)
|
|
| AR | Lethal Congenital Contracture Syndrome 2 | | | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian)
|
|
| AR | Lethal Congenital Contracture Syndrome 3 | | | phosphatidylinositol-4-phosphate 5-kinase, type I, gamma
|
|
| AR | Limb-Girdle, Muscular dystrophy, type 2A | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2B | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2C | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2D | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2E | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2F | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2G | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2H | | | Tripartite motif-containing 32
|
|
| AR | Limb-Girdle, Muscular dystrophy, type 2I | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2J | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2K | | | Protein-O-mannosyltransferase 1
|
|
| AR | Limb-Girdle, Muscular dystrophy, type 2L | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2M | | |
| AR | Limb-Girdle, Muscular dystrophy, type 2N | | | protein-O-mannosyltransferase 2
|
|
| AR | Limb-Girdle, Muscular dystrophy, type 2O | | | O-linked mannose beta1,2-N-acetylglucosaminyltransferase
|
|
| AR | Limb-Girdle, Muscular dystrophy, type 2Q | | | plectin 1, intermediate filament binding protein 500kDa
|
|
| AR | Long QT syndrome (Jervell and Lange-Nielsen cardioauditory syndrome) | | | potassium voltage-gated channel, Isk-related family, member 1
|
|
| AR | Marinesco-Sj**gren syndrome (cerebellar ataxia with cataract and myopathy) | | | SIL1 homolog, endoplasmic reticulum chaperone
|
|
| AR | Mitochondrial DNA depletion myopathy | | | Thymidine kinase 2, mitochondrial
|
|
| AR | Mitochondrial DNA depletion myopathy, encephalomyopathic form | | | succinate-CoA ligase, ADP-forming, beta subunit
|
|
| AR | Mitochondrial DNA depletion myopathy | | | ribonucleotide reductase M2 B (TP53 inducible)
|
|
| AR | Multiminicore disease with external ophtalmopegia | | | ryanodine receptor 1 (skeletal)
|
|
| AR | Multiminicore disease, classical form | | |
| AR | Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIA | | | electron-transfer-flavoprotein, alpha polypeptide
|
|
| AR | Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIB) | | | electron-transfer-flavoprotein, beta polypeptide
|
|
| AR | Multiple acyl-CoA dehydrogenase deficiency (MADD; Glutaric aciduria type IIC) | | | electron-transferring-flavoprotein dehydrogenase
|
|
| AR | Muscle hypertrophy | | | myostatin, muscular hypertrophy
|
|
| AR | Muscle-eye-brain disease | | |
| AR | Muscle-eye-brain disease | | | O-linked mannose beta1,2-N-acetylglucosaminyltransferase
|
|
| AR | Muscle-eye-brain disease | | | protein-O-mannosyltransferase 2
|
|
| AR | Myasthenic syndrome, with plectin defect | | | plectin 1, intermediate filament binding protein 500kDa
|
|
| AR | Myopathy congenital, with fiber-type disproportion | | |
| AR | Myopathy with exercise intolerance, Swedish type | | | iron-sulfur cluster scaffold homolog (E. coli)
|
|
| AR | Myopathy, congenital, with fiber-type disproportion | | | ryanodine receptor 1 (skeletal)
|
|
| AR | Myopathy, congenital, with fiber-type disproportion | | |
| AR | Myosclerosis | | |
| AR | Myosin lia myopathy, recessive | | | myosin, heavy polypeptide 2, skeletal muscle
|
|
| AR | Myosin storage myopathy and cardiomyopathy, recessive | | | myosin, heavy polypeptide 7, cardiac muscle, beta
|
|
| AR | Myotonia, recessive (Becker disease) | | | chloride channel 1, skeletal muscle (Thomsen disease, autosomal dominant)
|
|
| AR | Myotonia, recessive (Becker) | | | chloride channel 1, skeletal muscle (Thomsen disease, autosomal dominant)
|
|
| AR | Naxos disease | | |
| AR | Nemaline myopathy | | |
| AR | Nemaline myopathy | | |
| AR | Nemaline myopathy | | |
| AR | Nemaline myopathy with Escobar syndrome | | |
| AR | Neutral lipid storage disease with myopathy without ichthyosis | | | adipose triglyceride lipase (desnutrin)
|
|
| AR | Peripheral neuropathy and agenesis of the corpus callosum (Charlevoix disease) | | | potassium chloride cotransporter KCC3
|
|
| AR | Phosphoglycerate mutase deficiency | | | phosphoglycerate mutase 2 (muscle)
|
|
| AR | Pompe disease Glycogenosis, generalized, cardiac form (early and late onset) | | | acid alpha-glucosidase preproprotein
|
|
| AR | Potassium channel Long QT syndrome (Jervell and Lange-Nielsen cardioauditory syndrome) | | | potassium voltage-gated channel, KQT-like subfamily, member 1
|
|
| AR | Primary systemic carnitine deficiency | | | solute carrier family 22 member 5
|
|
| AR | Reccurrent myoglobinuria, autosomal recessive | | | Lipin 1 (phosphatidic acid phosphatase 1)
|
|
| AR | Recessive limb-girdle muscular dystrophy with primary alphadystroglycan defect | | | Dystroglycan1 (dystrophin-associated glycoprotein 1)
|
|
| AR | Refsum disease-1 (adult) | | | phytanoyl-CoA 2-hydroxylase
|
|
| AR | Refsum disease-2 (adult) | | | peroxisomal biogenesis factor 7
|
|
| AR | Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (Lipid storage myopathy) | | | electron-transferring-flavoprotein dehydrogenase
|
|
| AR | Rigid spine syndrome | | |
| AR | Rigid spine syndrome | | | four and a half LIM domain 1
|
|
| AR | Rippling muscle disease, recessive | | |
| AR | Sarcotubular myopathy | | | Tripartite motif-containing 32
|
|
| AR | Schwartz-Jampel syndrome | | |
| AR | Sensory ataxic neuropathy, dysarthria and ophtalmoparesis | | | polymerase (DNA directed), gamma
|
|
| AR | Sick sinus syndrome, recessive | | | voltage-gated sodium channel type V alpha
|
|
| AR | Sodium-channel myasthenia | | | sodium channel, voltage-gated, type IV, alpha
|
|
| AR | Spastic paraplegia 5, autosomal recessive | | | cytochrome P450, family 7, subfamily B, polypeptide 1
|
|
| AR | Spastic paraplegia 7, autosomal recessive | | |
| AR | Spastic paraplegia 11, autosomal recessive | | |
| AR | Spastic paraplegia 14, autosomal recessive | | ? - (3q27-q28) |
| AR | Spastic paraplegia 15, autosomal recessive (Kjellin syndrome) | | |
| AR | Spastic paraplegia 18 | | ? - (8p12-p11.21) |
| AR | Spastic paraplegia 20 (Troyer) | | |
| AR | Spastic paraplegia 21 (Mast) | | |
| AR | Spastic paraplegia 23 (Lison) | | ? - (1q24-q32) |
| AR | Spastic paraplegia 24 | | ? - (13q14) |
| AR | Spastic paraplegia 25 | | ? - (6q23.3-q24.1) |
| AR | Spastic paraplegia 26 | | ? - (12p11-q14) |
| AR | Spastic paraplegia 27 | | ? - (10q22-q24) |
| AR | Spastic paraplegia 28 | | ? - (14q21-q22) |
| AR | Spastic paraplegia 30 | | |
| AR | Spastic paraplegia 32, autosomal recessive | | ? - (14q12-q21) |
| AR | Spastic paraplegia 35, autosomal recessive | | |
| AR | Spastic paraplegia 39, autosomal recessive | | | patatin-like phospholipase domain containing 6
|
|
| AR | Spastic paraplegia 43, autosomal recessive | | ? - (19p13.11-q12) |
| AR | Spastic paraplegia 45, autosomal recessive | | ? - (10q24.3-q25.1) |
| AR | Spastic paraplegia 47, autosomal recessive | | ? - (1p13.2-1p12) |
| AR | Spastic paraplegia 48, autosomal recessive | | | hypothetical protein LOC9907 ?
|
|
| AR | Spastic paraplegia, complicated recessive (Sjogren-Larsson syndrome) | | | aldehyde dehydrogenase 3A2
|
|
| AR | Spinal muscular atrophy , type I (Werdnig-Hoffman ) | | | survival of motor neuron 1, telomeric
|
|
| AR | Spinal muscular atrophy with pontocerebellar hypoplasia | | | vaccinia related kinase 1
|
|
| AR | Spinal muscular atrophy, distal autosomal recessive 1 ( with respiratory distress) | | | immunoglobulin mu binding protein 2
|
|
| AR | Spinal muscular atrophy, distal autosomal recessive 2 | | ? - (9p21) |
| AR | Spinal muscular atrophy, distal autosomal recessive 3 | | ? - (11q13) |
| AR | Spinal muscular atrophy, distal autosomal recessive 4 | | | pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
| AR | Spinal muscular atrophy, type II (intermediate) | | | survival of motor neuron 1, telomeric
|
|
| AR | Spinal muscular atrophy, type III (Kugelberg-Welander) | | | survival of motor neuron 1, telomeric
|
|
| AR | Spinal muscular atrophy, type IV, adult form | | | survival of motor neuron 1, telomeric
|
|
| AR | Spinocerebellar ataxia with axonal neuropathy | | | Tyrosyl-DNA phosphodiesterase 1
|
|
| AR | Triglyceride storage disease with impaired long-chain fatty acid oxidation (Chanarin-Dorfman syndrome) | | | abhydrolase domain containing 5
|
|
| AR | Ullrich syndrome | | |
| AR | Ullrich syndrome | | |
| AR | Ullrich syndrome | | |
| AR | Ventricular tachycardia, catecholaminergic polymorphic, recessive | | | calsequestrin 2 (cardiac muscle)
|
|
| AR | Walker-Warburg syndrome | | |
| AR | Walker-Warburg syndrome | | | O-linked mannose beta1,2-N-acetylglucosaminyltransferase
|
|
| AR | Walker-Warburg syndrome | | |
| AR | Walker-Warburg syndrome | | | Protein-O-mannosyltransferase 1
|
|
| AR | Walker-Warburg syndrome | | | protein-O-mannosyltransferase 2
|
|